Close Menu

research grant

Look at the Science

Female grant applicants do about as well as their male colleagues when the review focuses on the science proposed, according to Nature News.

Over the next three years, the company and its partners will assess the OneRNA platform to diagnose bladder cancer, select treatment, and measure response and recurrence.

The new European initiative promises to deliver multiple new tests and methods for improving the treatment of breast cancer and rectal cancer.

The companies will use Sphere's Cyto-Mine system to develop an automated device for precise docking of large DNA cargoes in genome-edited cells.

Backed by €19 million in EU funding, the initiative, called BigData@Heart, will create a research platform that could change the way cardiovascular diseases are diagnosed and treated.

The firm plans to develop and evaluate the utility of an ethnically diverse group of metastatic prostate cancer patient-derived xenograft models.

Doudna will get $2.1 million to set up the Center for Genome Editing and Recording, and Zhang will get $1.1 million to develop tools for RNA interrogation.

The UK-based company plans to use the funds to develop an automated, benchtop device for the creation of high-value, genome-edited cell lines.

NASA's Jet Propulsion Laboratory is providing informatics services for an NCI-funded project to standardize cancer genomics ontologies.

The NIH proposes using a Grant Support Index to limit the total amount of grant support any one principal investigator can have.

Pages

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.